XML 79 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Compensation - Share Based Payment Award Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Apr. 01, 2017
Apr. 02, 2016
Mar. 28, 2015
Mar. 29, 2014
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 643,565 400,987 593,704 396,533
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 6.85 $ 6.93 $ 7.88 $ 10.33
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 643,565 0 398,905  
Grant date fair value per share $ 6.85 $ 0.00 $ 7.33  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 0 (5,592) (234)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 0.00 $ 14.64 $ 0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (400,987) (187,125) (201,500)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 6.93 $ 10.84 $ 11.63  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 2 years 5 months 5 days 1 year 1 year 9 months 22 days  
Awards Other Than Options Aggregate Intrinsic Value $ 4,409 $ 2,928 $ 3,657  
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1,607,917 1,081,804 835,841 1,115,601
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 6.41 $ 6.77 $ 8.90 $ 11.47
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 1,051,445 737,200 459,295  
Grant date fair value per share $ 6.63 $ 5.52 $ 6.33  
SharebasedcompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsTRSUgrantsinPeriodWeightedAverageGrantDateFairvalue $ 7.64 $ 11.75 $ 11.19  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (483,239) (360,349) (672,930)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 6.71 $ 5.52 $ 6.80  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (42,093) (130,888) (66,125)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 6.67 $ 7.66 $ 9.82  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 2 years 14 days 1 year 11 months 5 days 1 year 10 months 28 days  
Awards Other Than Options Aggregate Intrinsic Value $ 11,168 $ 7,781 $ 5,149  
Options and SARs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Balance (shares), beginning of period 2,155,600 2,229,046 1,898,409  
Weighted average exercise price, beginning of period $ 10.03 $ 12.52 $ 15.27  
Granted (shares) 0 467,000 634,523  
Granted, Weighted Average Exercise Price $ 0.00 $ 5.63 $ 6.91  
Exercised (shares) (22,500) (2,500) (8,250)  
Exercised, Weighted Average Exercise Price $ 6.23 $ 6.71 $ 7.26  
Expired or forfeited (shares) (191,097) (537,946) (295,636)  
Expired or forfeited, Weighted Average Exercise Price $ 19.20 $ 16.53 $ 18.30  
Balance (shares) , end of period 1,942,003 2,155,600 2,229,046  
Weighted average exercise price, end of period $ 9.17 $ 10.03 $ 12.52  
Vested and expected to vest (shares) 1,928,853      
Vested and expected to vest, Weighted Average Exercise Price $ 9.20      
Options exercisable (shares) 1,385,837      
Options exercisable, Weighted Average Exercise Price $ 10.39      
Options outstanding, weighted average remaining contractual term 4 years 9 months 25 days 5 years 4 months 6 days 4 years 5 months 12 days  
Options vested and expected to vest, weighted average remaining contractual term 4 years 9 months 18 days      
Options exercisable, weighted average remaining contractual term 3 years 7 months 13 days      
Options outstanding, aggregate intrinsic value $ 634 $ 904 $ 0  
Options vested and expected to vest, aggregate intrinsic value 619      
Options exercisable, aggregate intrinsic value $ 167